4D Molecular Therapeutics Inc (FDMT)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
Total Revenue | 500k | 1.25M | 298k | 240k | 20.2M | -19k | 28k | 5k |
Operating Income | -26.49M | -28.72M | -30.11M | -32.14M | -13.97M | -36.65M | -38.14M | -42.46M |
Pre Tax Income | -25.69M | -27.38M | -28.68M | -29.62M | -10.26M | -32.28M | -32.4M | -34.95M |
Net Income | -25.69M | -27.38M | -28.68M | -29.62M | -10.26M | -32.28M | -32.4M | -34.95M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -26.49M | -28.72M | -30.13M | -32.13M | -14.13M | -36.66M | -38.15M | -42.51M |
EBITDA | -25.98M | -27.71M | -29.08M | -31.06M | -12.98M | -35.55M | -36.96M | -41.26M |
Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 14.13M | 6.99M | 13.61M | 18.04M | 3.13M | 20.72M |
Operating Income | -10.4M | -50.76M | -56.66M | -71.33M | -110.03M | -112.87M |
Pre Tax Income | -9.55M | -49.31M | -56.69M | -71.32M | -107.49M | -100.84M |
Net Income | -9.55M | -49.31M | -56.69M | -71.32M | -107.49M | -100.84M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -1.863 | -9.52 | -2.125 | -2.213 | -3.295 | -2.359 |
EBIT | -10.4M | -50.81M | -56.85M | -71.45M | -110.07M | -113.05M |
EBITDA | -9.7M | -49.76M | -55.22M | -69.81M | -107.63M | -108.66M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.